Princeton Healthcare plans to acquire Diagnostics Labs in Brazil through it’s Brazilian Subsidiary, Princeton Healthcare do Brazil. The Diagnostic Clinical Labs of interest provides clinical services to a number of hospitals and health maintenance organizations within the Metropolitan Sao Paulo, District. Sao Paulo has a population of over 25M people, roughly two times the size of New York City. The Diagnostic Laboratory market is exploding in Brazil, which has a growing population with a high level of cardiovascular diseases, diabetes and lifestyle diseases.
PHI, through it’s Brazilian Subsidiary, Princeton Healthcare do Brazil, is raising funds to acquire two diagnostic labs within the Sao Paulo Region. The objective is to have a majority ownership, and management control of these two Diagnostic Laboratory Services Companies. Phase I will consist of the first will be the acquisition of a company which is generating $5.5M in revenues per annum. The company concentrates on providing clinical diagnostic tests. Phase II of this program will involve the complete acquisition of the key assets of a second lab.
PHI plans to use the funds to address the following: